TTY Biopharm Company Limited (4105) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TTY Biopharm Company Limited (4105:TWSE), powered by AI.

Current Price
$73.70
P/E Ratio
11.8
Market Cap
18.3B
Sector
Healthcare
What is the TTY Biopharm Company Limited stock price forecast?

TTY Biopharm Company Limited is currently trading at $73.70. View real-time AI analysis on Alpha Lenz.

What is TTY Biopharm Company Limited insider trading activity?

View the latest insider trading data for TTY Biopharm Company Limited on Alpha Lenz.

What is TTY Biopharm Company Limited's P/E ratio?

TTY Biopharm Company Limited's P/E ratio is 11.8.

TTY Biopharm Company Limited

TWSE · 4105
NT$73.70+0.00(+0.00%)
Ask about TTY Biopharm Company Limited's future dividend policy...
Alpha Chat Insight

TTY Biopharm Company Limited trades at a P/E of 11.8 (undervalued) with strong ROE of 22.3%. Operating margin of 26.4% indicates strong profitability.

Ask for details

Company Overview

TTY Biopharm Company Limited is a publicly traded pharmaceutical company specializing in the research, development, manufacture, and sale of pharmaceutical preparations. Established in 1960 and headquartered in Taipei, Taiwan, the company serves Taiwan’s pharmaceuticals and biotechnology sector, focusing primarily on supplying both branded and generic pharmaceutical products. As a mid-sized firm with approximately 342 employees, TTY Biopharm emphasizes innovation within therapeutics, contributing to the healthcare landscape through a diverse portfolio of medicines and treatments. The company has demonstrated robust financial growth, reporting annual revenues exceeding NT$6 billion and steady year-over-year increases in both revenue and net income. TTY Biopharm’s market presence and sustained operational history have positioned it as an influential player within Taiwan’s pharmaceutical industry, underpinning the supply chain and supporting medical needs across the region.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

NT$18.33BMarket Cap
NT$6.45BRevenue
0.00Shares Out
0Employees

Margins

57.66%Gross
36.41%EBITDA
26.42%Operating
32.93%Pre-Tax
25.64%Net

Valuation

11.75P/E
2.53P/B
2.84EV/Sales
7.60EV/EBITDA
11.38P/FCF

Growth (CAGR)

8.43%Rev 3Yr
8.86%Rev 5Yr
11.44%Op Inc 3Yr
12.29%Op Inc 5Yr
14.47%Net Inc 3Yr
11.07%Net Inc 5Yr

Returns

14.90%ROA
22.29%ROE
19.48%ROIC

Financial Health

NT$2.52BCash & Cash Equivalents
NT$775.88MNet Debt
40.95%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

TTY Biopharm Company Limited (ticker: 4105) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $18.3B.

The current price is 73.7 with a P/E ratio of 11.75x and P/B of 2.53x.

ROE is 22.29% and operating margin is 26.42%. Annual revenue is $6.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
TTY Biopharm Company Limited (4105) Stock Forecast 2026 $73.70 — Price, Financials & Analyst Targets | Alpha Lenz